Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

Also called NCT06319300

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06319300
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06319300. Randomized; single masking; primary purpose treatment. Start 2024-04-19 (actual); primary completion 2025-09-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
Condition
Diabetes Type 2
Intervention (Device)
AI-assisted insulin dose adjustment model
Intervention (Other)
doctor's insulin dose adjustment
Lead sponsor
Shanghai Zhongshan Hospital (class: other)
Collaborator
Fudan University (class: other)

Record details

Record id
cardio:ct-nct06319300
Content hash
e1b4f7d63049864420877f428b6fcfa318b0d40c52344b9d2e8d3f60bed16efe